Even for a newly minted Nobel laureate, downtime is hard to find. | Even for a newly minted Nobel laureate, downtime is hard ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

Immunotherapy has been one of the most promising advancements in cancer treatment. However, consistency in immunotherapy ...

Like the surface of the moon, new research published today in Cell finds the existence of craters on the surface of melanoma ...

First-in-class non-oncolytic arenavirus-based approach designed to induce targeted, effective, and durable anti-cancer activity against ...

A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...